SurgOnc Today®

In this episode of SurgOnc Today's Surgical Oncology Insight series, Dr. Mitchell Posner, Section Editor of the Education/Training Editorial Board section, discusses with Dr. Melissa Hogg the current state of robotic training in surgical oncology and directions for future research and practice, as reported in her article, "Minimally invasive training in surgical oncology: Current status and needs assessment."

In this episode of SurgOnc Today, Dr. Katherine Poruk from Mayo Clinic Florida and Dr. Erika Rangel of Massachusetts General Hospital discuss fertility and family planning for surgeons. Together, they explore how surgical culture impacts childbearing decisions, the risks of infertility and pregnancy complications, and the systemic changes needed to support surgeons with or without children.

In this episode of SurgOnc Today®, members of the Society of Surgical Oncology’s Disease Site Working Group will discuss several presentations from the ASBrS 2025 meeting that have significant implications for current practice or are potential inflection points for breast surgical oncologists in the future.

In this episode of SurgOnc Today, Dr. Miral Grandhi of Rutgers University and Dr. Neha Lad of Mount Sinai Medical Center—both members of the HPB Disease Site Working Group—provide a curated summary of the most impactful hepato-pancreato-biliary malignancy papers presented at the Society of Surgical Oncology’s 2025 Annual Meeting in Tampa, Florida. The discussion is moderated by Dr. Patricio Polanco of UT Southwestern Medical Center, who also serves as Vice Chair of the HPB Disease Site Working Group.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Pedro Dos Santos the results of a study that examined whether patients of the lowest income quartile with stage IA NSCLC experience worse survival after resection when compared to higher-income patients, as well as other identified survival disparities, as reported in as reported in the article article, "Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.”